From the Analyst's Couch in 2020

Trends in oncology drug innovation in China

Guanqiao Li
Yunhe Qin
Xiaoyuan Chen
From the Analyst's Couch05 Nov 2020
The failure to fail smartly

Steven Galson
Christopher P. Austin
John A. Wagner
From the Analyst's Couch23 Sept 2020
Immuno-oncology drug development forges on despite COVID-19

Samik Upadhaya
Vanessa M. Hubbard-Lucey
Jia Xin Yu
From the Analyst's Couch18 Sept 2020
Evolution of the COVID-19 vaccine development landscape

Tung Thanh Le
Jakob P. Cramer
Stephen Mayhew
From the Analyst's Couch04 Sept 2020
Developing blockbuster drugs: both nature and nurture

Lotte Berghauser Pont
Jiri Keirsse
Stephan Wurzer
From the Analyst's Couch08 Jun 2020
Cancer cell therapies: the clinical trial landscape

Jia Xin Yu
Samik Upadhaya
Vanessa M. Hubbard-Lucey
From the Analyst's Couch26 May 2020
RNA therapeutics on the rise

Feng Wang
Travis Zuroske
Jonathan K. Watts
From the Analyst's Couch27 Apr 2020
Breaking Eroom’s Law

Michael S. Ringel
Jack W. Scannell
Ulrik Schulze
From the Analyst's Couch16 Apr 2020
The COVID-19 vaccine development landscape

Tung Thanh Le
Zacharias Andreadakis
Stephen Mayhew
From the Analyst's Couch09 Apr 2020
The small-cell lung cancer drug market

Joshua B. N. Dawkins
Rachel M. Webster
From the Analyst's Couch31 Mar 2020
Tumour-agnostic therapies

Ann-Marie Looney
Khurram Nawaz
Rachel M. Webster
From the Analyst's Couch28 Jan 2020
Biopharma dealmaking in 2019

Amanda Micklus
Patricia Giglio
From the Analyst's Couch10 Jan 2020

Quick links

Filter By: